Ventilator-associated pneumonia (VAP) is the most frequent infection among
intensive care patients. There is a great deal of controversy about the met
hod for diagnosis and prevention of this infection. VAP is usually diagnose
d on a combination of clinical, microbiological, and radiographic criteria.
Although these criteria have a high sensitivity, specificity is low, resul
ting in unnecessary antibiotic use in many patients. Bronchoscopic techniqu
es, such as protected specimen brush and bronchaolveolar lavage, in combina
tion with quantitative culture techniques, do have a higher specificity. ho
wever, whether implementation of these techniques influences patient care a
nd to what cost, remains to be determined. Prevention of VAP relies on basi
c infection control practices. Many specific strategies interfering with co
lonization routes have been studied. so far, only the use of tropical nonab
sorbable antibodies, either of the whole digestive tract or the oropharynx
only, consistently reduced the incidence of VAP. however, the effects on pa
tient survival were disappointing and the possibility of selection of antib
iotic-resistant bacteria limit the widespread use of these strategies. (C)
1999 Elsevier Science Inc.